Ann: Quarterly Update and Appendix 4C, page-4

Whilst we are all fully aware of all the failures to-date and our scepticism regarding the focus of the Board in the past what positive take-aways did anyone have.

I for one am relieved we can move on without the DCF distraction, and the prospect of a singular focus accompanied with a Board reset. Equally the research regarding the benefits of buntine offer a value add in relation to weight management, which surely would be of interest to some markets.

Whilst I would love to see definitive sales commitments at a faster pace I appreciate companies need to undertake their own testing and market research. I still hold faith that once a few substantive sales are locked in we will see a snowball effect. This is definitely not a stock for the impatient, if it were not for the underpinning scientific evidence base on the potential of buntine I would have cut my losses a while ago.